A new treatment modality for colorectal cancers that do not respond to standard chemotherapy has been identified by Tatiana Petrova of the Lausanne Branch of the Ludwig Institute for Cancer Research and Michele De Palma of the EPFL.

Rebekka Schairer from Prof. Thome's lab just published an article in PNAS, which provides new molecular insights into the mechanisms of lymphocyte activation and lymphoma development. The report identifies the Ig3 domain of the protease MALT1 as a novel ubiquitin-binding domain that promotes MALT1 activation by monoubiquitination, through an allosteric mechanism.

The Universities of Lausanne, Fribourg and Zurich launch in September 2019 a new ‘Sinergia' research consortium entitled ‘Local power structures and transnational connections. New perspectives on elites in Switzerland, 1890-2020'.

The Lausanne Genomics Days 2020 will be held on February 10th-11th, 2020, Génopode, Auditorium C, UNIL-Sorge. Lausanne Genomics Days 2020 is an annual event sponsored by the University of Lausanne and the Conférence Universitaire de Suisse Occidentale (CUSO).

Insights from research at HEC Lausanne-UNIL ' It is commonly recognized that financial analysts tend to be too optimistic when forecasting stock prices, but why is it the case? That's the question Prof. Alain Schatt from HEC Lausanne (UNIL) and his co-authors decided to tackle in a recent research project.

Nicola Vannini, of the Ludwig Institute for Cancer Research Lausanne, with researchers from EPFL, finds that supplementing diet with an analogue of vitamin B3 could improve the treatment of some blood cancers.